331 related articles for article (PubMed ID: 34848794)
1. Coordination of retrotransposons and type I interferon with distinct interferon pathways in dermatomyositis, systemic lupus erythematosus and autoimmune blistering disease.
Kuriyama Y; Shimizu A; Kanai S; Oikawa D; Motegi SI; Tokunaga F; Ishikawa O
Sci Rep; 2021 Nov; 11(1):23146. PubMed ID: 34848794
[TBL] [Abstract][Full Text] [Related]
2. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
[TBL] [Abstract][Full Text] [Related]
3. Type I interferon gene signature test-low and -high patients with systemic lupus erythematosus have distinct gene expression signatures.
Brohawn PZ; Streicher K; Higgs BW; Morehouse C; Liu H; Illei G; Ranade K
Lupus; 2019 Nov; 28(13):1524-1533. PubMed ID: 31660791
[TBL] [Abstract][Full Text] [Related]
4. Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.
Chyuan IT; Tzeng HT; Chen JY
Cells; 2019 Aug; 8(9):. PubMed ID: 31450787
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of the type I interferon signaling pathway in lupus autoimmunity.
Gallucci S; Meka S; Gamero AM
Cytokine; 2021 Oct; 146():155633. PubMed ID: 34340046
[TBL] [Abstract][Full Text] [Related]
6. Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus.
Shen M; Duan C; Xie C; Wang H; Li Z; Li B; Wang T
Front Immunol; 2022; 13():962393. PubMed ID: 35967341
[TBL] [Abstract][Full Text] [Related]
7. The host defense peptide LL-37 a possible inducer of the type I interferon system in patients with polymyositis and dermatomyositis.
Lu X; Tang Q; Lindh M; Dastmalchi M; Alexanderson H; Popovic Silwerfeldt K; Agerberth B; Lundberg IE; Wick C
J Autoimmun; 2017 Mar; 78():46-56. PubMed ID: 28012697
[TBL] [Abstract][Full Text] [Related]
8. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.
Higgs BW; Liu Z; White B; Zhu W; White WI; Morehouse C; Brohawn P; Kiener PA; Richman L; Fiorentino D; Greenberg SA; Jallal B; Yao Y
Ann Rheum Dis; 2011 Nov; 70(11):2029-36. PubMed ID: 21803750
[TBL] [Abstract][Full Text] [Related]
9. The synchronized gene expression of retrotransposons and type I interferon in dermatomyositis.
Kuriyama Y; Shimizu A; Kanai S; Oikawa D; Tokunaga F; Tsukagoshi H; Ishikawa O
J Am Acad Dermatol; 2021 Apr; 84(4):1103-1105. PubMed ID: 32439465
[No Abstract] [Full Text] [Related]
10. Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.
Wu L; Qin Y; Xia S; Dai M; Han X; Wu Y; Zhang X; Ma J; Wang Y; Tang Y; Liu Z; Zhu W; Jallal B; Yao Y; Qu B; Shen N
Arthritis Rheumatol; 2016 May; 68(5):1222-32. PubMed ID: 26663909
[TBL] [Abstract][Full Text] [Related]
11. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus.
Oke V; Gunnarsson I; Dorschner J; Eketjäll S; Zickert A; Niewold TB; Svenungsson E
Arthritis Res Ther; 2019 Apr; 21(1):107. PubMed ID: 31036046
[TBL] [Abstract][Full Text] [Related]
12. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
[TBL] [Abstract][Full Text] [Related]
13. The important roles of type I interferon and interferon-inducible genes in systemic lupus erythematosus.
Luo S; Wang Y; Zhao M; Lu Q
Int Immunopharmacol; 2016 Nov; 40():542-549. PubMed ID: 27769023
[TBL] [Abstract][Full Text] [Related]
14. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
[TBL] [Abstract][Full Text] [Related]
15. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis.
Lei W; Luo Y; Lei W; Luo Y; Yan K; Zhao S; Li Y; Qiu X; Zhou Y; Long H; Zhao M; Liang Y; Su Y; Lu Q
Scand J Rheumatol; 2009; 38(5):369-74. PubMed ID: 19444718
[TBL] [Abstract][Full Text] [Related]
16. Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?
Kyogoku C; Smiljanovic B; Grün JR; Biesen R; Schulte-Wrede U; Häupl T; Hiepe F; Alexander T; Radbruch A; Grützkau A
PLoS One; 2013; 8(12):e83776. PubMed ID: 24391825
[TBL] [Abstract][Full Text] [Related]
17. Fatigue in systemic lupus erythematosus and other autoimmune skin diseases.
Tarazi M; Gaffney RG; Pearson D; Kushner CJ; Werth VP
Br J Dermatol; 2019 Jun; 180(6):1468-1472. PubMed ID: 30269332
[TBL] [Abstract][Full Text] [Related]
18. Muscle Expression of Type I and Type II Interferons Is Increased in Juvenile Dermatomyositis and Related to Clinical and Histologic Features.
Moneta GM; Pires Marafon D; Marasco E; Rosina S; Verardo M; Fiorillo C; Minetti C; Bracci-Laudiero L; Ravelli A; De Benedetti F; Nicolai R
Arthritis Rheumatol; 2019 Jun; 71(6):1011-1021. PubMed ID: 30552836
[TBL] [Abstract][Full Text] [Related]
19. Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?
Wahadat MJ; Bodewes ILA; Maria NI; van Helden-Meeuwsen CG; van Dijk-Hummelman A; Steenwijk EC; Kamphuis S; Versnel MA
Arthritis Res Ther; 2018 Jan; 20(1):4. PubMed ID: 29321042
[TBL] [Abstract][Full Text] [Related]
20. Genetic associations in type I interferon related pathways with autoimmunity.
Delgado-Vega AM; Alarcón-Riquelme ME; Kozyrev SV
Arthritis Res Ther; 2010; 12 Suppl 1(Suppl 1):S2. PubMed ID: 20392289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
